tiprankstipranks
Advertisement
Advertisement
Anixa Biosciences says Korean MOIP issues Notice of Allowance for new patent
PremiumThe FlyAnixa Biosciences says Korean MOIP issues Notice of Allowance for new patent
3M ago
Anixa Advances Ovarian Cancer CAR-T With Higher Dosing
Premium
Company Announcements
Anixa Advances Ovarian Cancer CAR-T With Higher Dosing
4M ago
Anixa provides update on Phase 1 ovarian cancer CAR-T clinical trial
Premium
The Fly
Anixa provides update on Phase 1 ovarian cancer CAR-T clinical trial
4M ago
Anixa Biosciences says all primary endpoints met in breast cancer vaccine trial
PremiumThe FlyAnixa Biosciences says all primary endpoints met in breast cancer vaccine trial
6M ago
Anixa Biosciences’ CAR-T therapy granted WHO approval of non-proprietary name
Premium
The Fly
Anixa Biosciences’ CAR-T therapy granted WHO approval of non-proprietary name
7M ago
Anixa Biosciences awarded patent covering breast cancer vaccine technology
Premium
The Fly
Anixa Biosciences awarded patent covering breast cancer vaccine technology
7M ago
Anixa Biosciences: Promising Clinical Progress and Financial Stability Underpin Buy Rating
PremiumRatingsAnixa Biosciences: Promising Clinical Progress and Financial Stability Underpin Buy Rating
9M ago
Anixa Biosciences files $200M mixed securities shelf
Premium
The Fly
Anixa Biosciences files $200M mixed securities shelf
9M ago
Promising Advancements and Strategic Positioning Propel Anixa Biosciences to a Buy Rating
Premium
Ratings
Promising Advancements and Strategic Positioning Propel Anixa Biosciences to a Buy Rating
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100